ArticleInternal medicine (Tokyo, Japan)2022

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance.

Chihiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.